| 000 | 01085 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513233302.0 | ||
| 264 | 0 | _c20010412 | |
| 008 | 200104s 0 0 eng d | ||
| 022 | _a1464-8431 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpencer, D M | |
| 245 | 0 | 0 |
_aDevelopments in suicide genes for preclinical and clinical applications. _h[electronic resource] |
| 260 |
_bCurrent opinion in molecular therapeutics _cAug 2000 |
||
| 300 |
_a433-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aCytosine Deaminase |
| 650 | 0 | 4 |
_aEscherichia coli _xenzymology |
| 650 | 0 | 4 |
_aGenetic Therapy _xadverse effects |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xtherapy |
| 650 | 0 | 4 |
_aHerpesvirus 1, Human _xenzymology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xtherapy |
| 650 | 0 | 4 |
_aNucleoside Deaminases _xgenetics |
| 650 | 0 | 4 |
_aThymidine Kinase _xgenetics |
| 773 | 0 |
_tCurrent opinion in molecular therapeutics _gvol. 2 _gno. 4 _gp. 433-40 |
|
| 999 |
_c11186607 _d11186607 |
||